Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease
2022 · Nature Communications · 68 citations
https://doi.org/10.1038/s41467-022-33110-5
M
Marco Allinovi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
129
Papers
2.0K
Citations
26
h-index
51
i10-index
Marco Allinovi is an academic researcher from Amyloidosis Foundation. The author has contributed to research in topics: Renal Diseases and Glomerulopathies & Amyloidosis: Diagnosis, Treatment, Outcomes & Ultrasound in Clinical Applications. The author has an h-index of 26, co-authored 110 publications.
ORCID: 0000-0001-9949-3543Papers by this author
worksFinding covert fluid: methods for detecting volume overload in children on dialysis
2016 · Pediatric Nephrology · 42 citations
https://doi.org/10.1007/s00467-016-3431-4
Anti-slit Antibodies against Podocin and Kirrel1 in Pediatric and Adult Podocytopathies
2025 · Journal of the American Society of Nephrology · 28 citations
https://doi.org/10.1681/asn.0000000642
Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist
2022 · Internal and Emergency Medicine · 25 citations
https://doi.org/10.1007/s11739-022-02958-2
The Role of Rituximab in Primary Focal Segmental Glomerular Sclerosis of the Adult
2022 · Kidney International Reports · 24 citations
https://doi.org/10.1016/j.ekir.2022.05.024
Beyond playing games: nephrologist vs machine in pediatric dialysis prescribing
2018 · Pediatric Nephrology · 6 citations
https://doi.org/10.1007/s00467-018-4021-4
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat